Conditional deletion of Fbxo22 in HSC cells of mice significantly impairs MLL-AF9-induced mouse AML development and the function of LSCs during serial transplantation without significant influences on normal hematopoiesis. The gene discussed is FBXO22; the disease is acute myeloid leukemia.